Health Care/Hospital

HTL Biotechnology, market leader in biopolymers, acquires the Modern Meadow's human recombinant collagen platform for beauty and biomedical applications

JAVENÉ, France, May 6, 2024 /PRNewswire/ -- HTL Biotechnology strengthens its position as a global leader in the production and development of pharmaceutical-grade biopolymers by acquiring the beauty and biomedical division of American company Modern Meadow (Nutley, NJ). Notably, this acquisitio...

2024-05-07 07:00 942

ThinkCyte Launches New Website and Showcases VisionSortTM at Global Events

TOKYO, May 7, 2024 /PRNewswire/ -- ThinkCyte today announced that it will be presenting at three major international scientific conferences in the first week of May and the launch of itsupdated website. The company will have a presence at the American Society for Immunology (AAI) fromMay 3rd to 7...

2024-05-06 23:25 986

German car manufacturer visits HoneyNaps, a South Korean sleep tech company, to develop new automotive healthcare applications

Monitoring biosignals for both drivers and passengers - Analyzing and diagnosing with FDA-approved algorithm SEOUL, South Korea, May 6, 2024 /PRNewswire/ -- Amid the rapid advancement in automobile healthcare and digital healthcare markets, global car manufacturers are racing to adopt cutting ed...

2024-05-06 22:00 946

Datasea Pre-Announces Estimated Revenue of $12.5 Million for April 2024 Supporting its Prior Revenue Guidance of $86 Million for Fiscal 2024

DTSS on Track to Achieve Record Revenue for Fiscal 2024 as it Further Penetrates China's$528 Billion 5G Market BEIJING, May 6, 2024 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a digital technology company incorporated inNevada and engaged in innovative business seg...

2024-05-06 22:00 1466

21st.BIO unveils a new pilot plant facility to accelerate impact of biotech innovations globally

* Combining world-class industrially proven technology with fermentation capacity, 21st.BIO helps customers get to scale faster, in a risk-mitigated and cost-effective way. * Margrethe Vestager, Executive Vice President of the European Commission, was onsite to inaugurate the pilot facility, ...

2024-05-06 15:53 974

Global Fitness Giant Anytime Fitness Celebrates 25-Club Milestone in Indonesia

TANGERANG, Indonesia, May 6, 2024 /PRNewswire/ -- Anytime Fitness, the world's largest fitness franchise with over 5 million members throughout 5,500 clubs across 42 countries on all seven continents, announced its milestone 25th club in the health-crazed Indonesian market. Located at the bustlin...

2024-05-06 15:49 1244

Healthplex Expo, Natural & Nutraceutical Products China 2024 to Shine in Shanghai in June

SHANGHAI, April 30, 2024 /PRNewswire/ -- "Healthplex Expo 2024, Natural & Nutraceutical Products China 2024" (HNC), co-organized by CCCMHPIE and Sinoexpo Informa Markets, will be held during19-21 June 2024 at the National Exhibition and Convention Center (NECC)in Shanghai. HNC expo will be co-loc...

2024-05-06 13:29 1228

Dr. Sarah Salvilla to lead new FWD HealthyMe business

HONG KONG, May 6, 2024 /PRNewswire/ -- FWD Group Holdings Limited ("FWD Group" or "FWD") today announced the appointment of Dr.Sarah Salvilla as Group Chief Health Officer to lead a new health business unit, FWD HealthyMe.

2024-05-06 11:17 1162

Alphamab Oncology to Present Chinese Clinical Data of JSKN003 for the Treatment of HER2-expressing Solid Tumors for the First Time at the 2024 ASCO Annual Meeting

SUZHOU, China, May 6, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that data from the clinical study conducted inChina (JSKN003-102) of anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 for the treatment of HER2-expressing advanced solid tumors, will be presente...

2024-05-06 10:25 1864

Palm Oil Giant Musim Mas Pledges Third Tranche of S$5 million In Boost to Local Charities

Latest donation makes it S$16 million in 5 years as the Singapore-based company reaffirms commitment to improving lives SINGAPORE, May 6, 2024 /PRNewswire/ -- Palm oil giant Musim Mas Group has announced its latestS$5 million donation to selected local charities. This brings the group's total do...

2024-05-06 09:00 1228

H2:iD HYDROGEN WATER ON THE GO™ PRESENTS GROUNDBREAKING APPROACH TO WELLNESS WITH NATURAL ENERGY BOOST

* H2:iD delivers 1,200% more parts per million (PPM) of Hydrogen Gas compared to conventional alternatives. * Hydrogen Water offers a calm energy boost, unlike caffeine, with a study revealing its nuanced impact on alertness compared to caffeine in sleep-deprived individuals. SINGAPORE, May 6...

2024-05-06 09:00 1181

World Lupus Federation Global Survey Finds 91% of People with Lupus Report Using Oral Steroids to Treat Lupus

Global public urged to share survey results and lupus facts on May 10 for World Lupus Day WASHINGTON, May 6, 2024 /PRNewswire/ -- A recent global survey conducted by the World Lupus Federation reported that 91% of survey respondents were taking or have taken oral steroids to treat their lupus. O...

2024-05-06 08:00 1084

VYNDAMAX® (tafamidis) PBS-listed for adult patients with wild-type or hereditary transthyretin amyloid cardiomyopathy (ATTR-CM) with New York Heart Association (NYHA) Class I-II heart failure

* VYNDAMAX has been listed on the Pharmaceutical Benefits Scheme (PBS) for adult patients with wild-type or hereditary transthyretin amyloid cardiomyopathy (ATTR-CM)with New York Heart Association (NYHA) Class I-II heart failure.[1] * ATTR-CM is a debilitating and often fatal condition that l...

2024-05-04 18:00 2188

United Imaging to Unveil Industry-Leading MRI Advancements at ISMRM 2024

Ultra-high-field technology, ultra-high-gradient technology, and advances in artificial intelligence take center stage. SHANGHAI, May 4, 2024 /PRNewswire/ -- United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, will unveil its latest MRI technolog...

2024-05-04 09:00 3142

HanAll Biopharma Announces Initiation of Phase III Randomized, Double-Masked Vehicle Controlled VELOS-4 Trial Evaluating Tanfanercept for Treatment of Dry Eye Disease

* HanAll has initiated a Phase III VELOS-4 study to evaluate the efficacy and safety of tanfanercept in dry eye based on the findings from the previous Phase III VELOS-3 study. * Tanfanercept demonstrated statistically significant improvement on the secondary outcome measure, Schirmer testing...

2024-05-03 19:00 1921

Hang Seng Insurance Introduces FortuneLife Deferred Annuity Life Insurance Plan with Enhanced Benefit to Support Stable Retirement

HONG KONG, May 3, 2024 /PRNewswire/ -- Hang Seng Insurance announced the launch of the enhanced version of the FortuneLife Deferred Annuity Life Insurance Plan ('FortuneLife'), a Qualifying Deferred Annuity Policy ('QDAP'). This updated plan features a projected Total Internal Rate of Returns ('I...

2024-05-03 14:47 6224

Zepp Health's Amazfit Unveils Bip 5 Unity: Elevating Health and Style Every Step of the Way

MILPITAS, Calif., May 2, 2024 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health") (NYSE:ZEPP ), a global leader in smart...

2024-05-02 23:00 1269

Boryung Launches 2024 Humans In Space Challenge: Sending Experiments into Orbit

* Boryung to support the launch of space experiments into orbit for selected startups and researchers * Held for the third consecutive year, HIS presents an expanded ecosystem of engagements with NASA, ISS National Lab,MIT, and major space companies * Humans In Space(HIS) will serve as a glo...

2024-05-02 20:00 1132

Bio Basic Asia Pacific Offers Free Re-Sequencing and Gel Analysis for Sanger Sequencing Services

SINGAPORE, May 2, 2024 /PRNewswire/ -- Bio Basic Asia Pacific , the regional branch of BBI Life Sciences Corporation established inSingapore in 2016, announces an initiative to enhance the quality and reliability of itsSanger sequencing services

2024-05-02 16:33 2508

Clarivate Enhances Cortellis CMC Intelligence with Post-Approval Module to Accelerate Regulatory Success

Enhancements enable pharma, biotech and generics companies to streamline regulatory tracking and optimize life cycle management for small molecules and biologics  LONDON, May 2, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announ...

2024-05-02 15:00 1606
12345 ... 808